Febuxostat is a prescription medication used to reduce uric acid levels in people with gout and to treat long-term kidney disease caused by high levels of uric acid. It works by blocking the action of an enzyme in the body called xanthine oxidase, which helps to reduce the production of uric acid. Febuxostat is usually taken once daily with or without food. Common side effects include nausea, diarrhea, and headaches.
Febuxostat is a prescription medication used to manage gout in adults [1, 2, 3]. Here's a rundown of its key features:
- Purpose: Lowers uric acid levels in the blood to prevent gout attacks [1, 2, 3].
- Mechanism of action: Febuxostat belongs to a drug class called xanthine oxidase inhibitors [1, 2, 3]. It works by blocking an enzyme (xanthine oxidase) that's involved in the production of uric acid in the body [1, 2, 3].
- Usuality: Febuxostat is typically prescribed when other gout medication, allopurinol, is ineffective or causes severe side effects [1, 2, 3].
Some important points to remember about Febuxostat:
- It's not a cure for gout: Febuxostat helps control gout but doesn't eliminate the underlying condition [2, 3].
- Doesn't treat existing gout attacks: Febuxostat is for long-term management, not for treating ongoing gout flares [2, 3].
- Potential increased cardiovascular risk: Recent studies suggest a possible increased risk of heart-related problems and stroke with Febuxostat use [1, 2]. It's crucial to discuss this with your doctor before starting Febuxostat.
Always consult a doctor regarding Febuxostat:
- They can assess if Febuxostat is the right medication for your specific situation, considering your medical history and potential risks.
- They will determine the appropriate dosage and monitor your progress during treatment.
Here are some reliable sources for further information on Febuxostat:
- MedlinePlus: https://www.webmd.com/drugs/2/drug-151868/febuxostat-oral/details
- Johns Hopkins Arthritis Center: https://pubmed.ncbi.nlm.nih.gov/19447778/
- Versus Arthritis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827920/
Anatomical Therapeutic Chemical Classification
M - Musculo-skeletal system
M04 Antigout preparations
M04A - Antigout preparations
M04AA Preparations inhibiting uric acid production
ATC Code
External Links
Febuxostat